Mounjaro 7.5mg (Tirzepatide) Intermediate Strength for Advanced Results. Mounjaro 7.5mg is a mid-range maintenance dose of Tirzepatide, the first dual GIP and GLP-1 receptor agonist. This once-weekly injection is designed for individuals who have completed the initial 2.5mg and 5mg phases and require an increased therapeutic effect. It works by intensifying the hormonal signals that regulate blood sugar and appetite, helping to overcome weight loss plateaus. Key Highlights: Therapeutic Bridge: Designed to move users safely from starting doses to higher strengths. Enhanced Appetite Suppression: Provides a stronger effect on satiety and "food noise" reduction. Dual-Action Potency: Actively manages both insulin response and digestive speed. Administration: Subcutaneous injection once weekly on the same day each week. Storage: Store in the refrigerator (2°C to 8°C). Store in the original carton to protect from light.